David S. Grayzel, Director of Q32 Bio QTTB, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/12.

DG

DG

David S. Grayzel

Director

Company

Q32 Bio QTTB

First filing

23/01/05

Trades

18 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Jade BiosciencesJBIO	Open-market sale	24/04/09	24/04/11	11,882 sh	$28.15	$334,478.3	−45.0%